Asamedic AS is a Norwegian pharmaceutical company focused on its patented emergency heart attack treatment, Coxor®. This fast-acting, fully dissolved acetylsalicylic acid formulation—available as both OTC and Rx—is designed for immediate use at the onset of symptoms, enabling rapid intervention when every second counts. Approved through the European DCP process and launched in Norway, Coxor has been very well received by key opinion leaders, regulatory authorities, and the market. Early commercial uptake has been strong, confirming unmet medical need backed by international guidelines. Asamedic is now actively seeking global licensing and distribution partners to bring this life-saving innovation to new markets.
Company Details
- Employees
- 7
- Address
- Nordre Follo, Viken
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.asamedic.com
- HQ
- Nordre Follo, Viken
Asamedic Questions
Asamedic's website is https://www.asamedic.com
Asamedic's LinkedIn profile is https://no.linkedin.com/company/asamedic
Asamedic has
7 employees.
View email and phone details for 7
employees at Asamedic.
Asamedic's industry is
Pharmaceutical Manufacturing
Asamedic's top competitors are
Advanced Technology Company,
Asamedical Group,
Albatha Group,
Stiftung Für Betagte Münsingen,
Modern Pharmaceutical Llc,
Stiegelmeyer Group International,
Ge Healthcare,
Ansea,
Gulf Drug Llc,
Santen.
Asamedic's categories are Pharmaceutical Manufacturing
